Amifostine
Overview
Categories
- 4 Antidotes and other substances used in poisonings
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Amifostine's dosage details are as follows:
Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
200 to 200 mg/m.sq | 200 (200) | 24 hourly | IV | For prevention of xerotamine infuse over 3 minutes started 15-30 minutes before Radiotherapy. |
740 to 740 mg/m.sq | 740 (740) | As recommended. | IV | To reduce cisplatin induced renal toxicity if doses of cisplatin of less tgan 100 mg/m.sq are used. Give as IV infussion over 15 minutes starting no more than 30 minutes before the antineoplastic therapy. |
910 to 910 mg/m.sq | 910 (910) | 24 hourly | IV | Subsequent doses should be reduced to 740 mg/m.sq in patient unable tolerate the full dose. |
Paedriatic Dosage (20kg)
|
740 to 740 mg/m2 | 740 (740) | As recommended. | IV | To reduce cisplatin induced renal toxicity, if doses of cisplatin of less than 100mg/m2 are used. Gi |
200 to 200 mg/m2/day | 200 (200) | As recommended. | IV-Inf | |
Neonatal Dosage (3kg)
|
No data regarding the neonatal dosage details of Amifostine is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Acepromazine (Maleate)
Back to top
Previous Drug Generic - Next Drug Generic